| HLOSF Stock | | | USD 2.75 0.65 30.95% |
The pattern recognition view organizes Three Line Strike recognition and supporting indicators around Healios KK. It emphasizes pattern recognition signals tied to momentum and continuation while keeping volatility, risk, and performance context in view.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was eight with a total number of output elements of fifty-three. The function did not return any valid pattern recognition events for the selected time horizon. Healios KK Three-Line Strike is one of pattern recognition indicators that helps to determine continuation of Healios KK trend.
Most technical analysis of Healios KK help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Healios from various momentum indicators to cycle indicators. When you analyze Healios charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. Healios K.K. was incorporated in 2011 and is headquartered in Tokyo, Japan. Healios K is traded on OTC Exchange in the United States. Liquidity and trading activity can influence how quickly new information is reflected in Healios KK's price. Lower trading activity may introduce occasional variability in execution conditions. Healios KK has a market cap of 882.08 M, P/E of 3.68, ROE of -68.29%.
Methodology
Unless otherwise specified, financial data for Healios KK is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Healios (USA Stocks:HLOSF) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Underlying inputs rely on public filings and market reference sources, including disclosures from U.S. Securities and Exchange Commission (SEC) via EDGAR. Values may reflect publication timing differences. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
Healios KK may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
This content is curated and reviewed by:
Rifka Kats - Member of Macroaxis Editorial Board
Tracking Healios KK inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.